Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Journal of the American College of Cardiology
|
September 1, 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
D R Holmes, E R Bates, N S Kleiman, et al.
The American Journal of Cardiology
|
February 1, 1991
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group
P Clemmensen, E R Bates, R M Califf, et al.
Chest
|
May 1, 1985
Quantitative assessment of global and regional left ventricular function with low-contrast dose digital subtraction ventriculography
G B Mancini, J M Hodgson, V Legrand, et al.
Circulation
|
November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation
D R Holmes, P B Berger, J S Hochman, et al.
American Heart Journal
|
October 1, 1990
Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device
A M Lincoff, J J Popma, E R Bates, et al.
Journal of the American College of Cardiology
|
February 1, 1991
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction
E G Nabel, E J Topol, A Galeana, et al.
The American Journal of Cardiology
|
October 1, 1986
Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction
A Y Fung, P Lai, E J Topol, et al.
Journal of the American College of Cardiology
|
January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality
E R Bates, R M Califf, R S Stack, et al.
Circulation
|
February 1, 1987
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction
E J Topol, W W O'Neill, A B Langburd, et al.
Lancet (London, England)
|
January 11, 1997
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial
D R Holmes, R M Califf, F Van de Werf, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Journal of the American College of Cardiology
|
September 1, 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
D R Holmes, E R Bates, N S Kleiman, et al.
The American Journal of Cardiology
|
February 1, 1991
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group
P Clemmensen, E R Bates, R M Califf, et al.
Chest
|
May 1, 1985
Quantitative assessment of global and regional left ventricular function with low-contrast dose digital subtraction ventriculography
G B Mancini, J M Hodgson, V Legrand, et al.
Circulation
|
November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation
D R Holmes, P B Berger, J S Hochman, et al.
American Heart Journal
|
October 1, 1990
Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device
A M Lincoff, J J Popma, E R Bates, et al.
Journal of the American College of Cardiology
|
February 1, 1991
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction
E G Nabel, E J Topol, A Galeana, et al.
The American Journal of Cardiology
|
October 1, 1986
Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction
A Y Fung, P Lai, E J Topol, et al.
Journal of the American College of Cardiology
|
January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality
E R Bates, R M Califf, R S Stack, et al.
Circulation
|
February 1, 1987
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction
E J Topol, W W O'Neill, A B Langburd, et al.
Lancet (London, England)
|
January 11, 1997
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial
D R Holmes, R M Califf, F Van de Werf, et al.
Page
of 12